NCT00510549View on ClinicalTrials.gov

Comparison of the Impact of Dialysis Treatment Type on Patient Survival

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
End Stage Renal Disease
Interventions
PROCEDURE

Modality: Peritoneal Dialysis

Peritoneal Dialysis: CAPD; Hemodialysis: 3 times/week

Trial Locations (2)

Unknown

Bejing No.3 Hospital, Beijing

Renji Hospital, Shanghai, Shanghai

All Listed Sponsors
lead

Baxter Healthcare Corporation

INDUSTRY

NCT00510549 - Comparison of the Impact of Dialysis Treatment Type on Patient Survival | Biotech Hunter | Biotech Hunter